Aptamer-based multiplexed proteomic technology for biomarker discovery
about
Generation of high-affinity DNA aptamers using an expanded genetic alphabetSelection and Biosensor Application of Aptamers for Small MoleculesProteomics for prediction of disease progression and response to therapy in diabetic kidney diseaseBig data for bipolar disorder.Methods for Improving Aptamer Binding AffinityFrom selection hits to clinical leads: progress in aptamer discoveryMolecular Selection, Modification and Development of Therapeutic Oligonucleotide AptamersGeneration of Aptamers with an Expanded Chemical RepertoireNucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical SensingBioanalytical chemistry of cytokines--a reviewIn vitro selection using modified or unnatural nucleotidesUnique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targetsCrystal Structure of Interleukin-6 in Complex with a Modified Nucleic Acid LigandAdvances in targeted proteomics and applications to biomedical researchAptamers in analytics.Manipulating the in vivo immune response by targeted gene knockdownGDF11 Increases with Age and Inhibits Skeletal Muscle RegenerationGrowth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophyProbing the limits of aptamer affinity with a microfluidic SELEX platformChallenges and opportunities for small molecule aptamer developmentMeasurement of cetuximab and panitumumab-unbound serum EGFR extracellular domain using an assay based on slow off-rate modified aptamer (SOMAmer) reagentsDiscovering aptamers by cell-SELEX against human soluble growth factors ectopically expressed on yeast cell surfaceRNA plasticity and selectivity applicable to therapeutics and novel biosensor developmentProtein signature of lung cancer tissuesUnlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancerProteinSeq: high-performance proteomic analyses by proximity ligation and next generation sequencingFit for the Eye: Aptamers in Ocular DisordersThe influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathologyEmerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.Aptamer in bioanalytical applications.Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker.Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.Integrating and mining diverse data in human immunological studies.A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processesAptamers and the next generation of diagnostic reagents.Methylation potential associated with diet, genotype, protein, and metabolite levels in the Delta Obesity Vitamin StudyAptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis.Role of soluble endothelial cell-selective adhesion molecule biomarker in albuminuria and kidney function changes in patients with coronary artery disease: the Heart and Soul Study.Particle display: a quantitative screening method for generating high-affinity aptamers.
P2860
Q22122129-FB034405-CD8F-447D-8512-C78ED33AFDC2Q26744467-B8899853-04EE-4FC7-B3DB-8BF1666CE0B3Q26747131-331AEC4E-5C83-4C43-A92C-86CFB28B1CB3Q26749257-759976C0-8883-477B-97E1-2700398ECBDDQ26752642-EBD8D177-8495-4253-BF0B-469C0442186DQ26752799-9546E527-0F99-4CD0-8BEF-E75C54FFA106Q26765458-A157843A-BF3D-43CE-B3BF-5D2B4DE6C895Q26782794-CB3AE408-57DD-49C9-A315-B457DB4A4D2BQ26825644-85A98E09-13D9-4F30-A09F-BE630E01FCA1Q26851317-C01DF363-0DDB-4C32-B4F5-62A83012B51CQ26864079-463686C5-6728-469E-A129-2AD30DFBB790Q27675037-B333FA8E-D19F-4F9C-93AD-B420E4644CFEQ27681282-7C059396-F8C9-48D9-891E-06FB8C56A214Q28066912-23AD3964-8EAC-48BB-B2A9-BD3E5D7FD7B8Q28075607-DA3C6F21-E33E-4CBA-B38B-F0F1401BEBBCQ28083494-4173351E-2CA8-49C4-ACDB-016196D336D5Q28262319-1240BF4A-151C-48B9-A3FA-224074C6787CQ28290417-F10A0DF7-5674-443A-89DA-6347901169C6Q28477954-BA744000-D2ED-4050-94F5-66D553EB01CBQ28484847-6B68A7FF-816A-4B68-91D2-F5415F90BC28Q28535487-3DEB91DA-553D-4D55-AD47-18801A0A7589Q28541656-63FF2930-2B0D-48B6-A861-9926D2B3C923Q28727743-C25558E0-CD60-494E-AE35-5EA6F48AAC7AQ28730650-9343B640-FAE1-4951-A41A-4CE0B5C7A622Q28744369-25F9BA85-33BE-4BA1-830D-0D80DC5C8B41Q28744412-EE8AF4DF-BBA2-46C8-9F13-086C71F38B7DQ28828283-B9AEA1D7-22D6-403D-BDBA-0CB561E575FEQ29994562-A92E38EE-27EA-4098-94E1-FD7093143018Q30234679-B1A02840-D100-431D-B788-76BABB1C3E08Q30466572-295D6584-23EF-4434-A548-81EFD8AA936DQ30513800-B5AE3641-C259-4FC5-AA99-595073BE0FFCQ30670593-2168C2C4-85CE-4A4E-B9A2-1C2269019925Q30733394-217605D8-B70B-401F-9C98-CB5BCA544E4EQ31171499-06B8D142-25DD-4063-BD37-62970C96FA15Q33601748-4B3648D5-C5E9-49A1-A2A7-510162FCC076Q33615065-F5A394D9-94F1-45F2-891F-A9DEA5A93B77Q33632915-25D9DDB7-95D7-4F9C-9EBD-8F3FD864611DQ33638930-4E27F479-7262-462A-8271-05FDF04DA25FQ33760848-F875578F-D4CA-4F55-8093-CB38E94B221EQ33786340-7E9F9051-B0CA-4A25-8365-E4CA6708E80D
P2860
Aptamer-based multiplexed proteomic technology for biomarker discovery
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Aptamer-based multiplexed proteomic technology for biomarker discovery
@ast
Aptamer-based multiplexed proteomic technology for biomarker discovery
@en
Aptamer-based multiplexed proteomic technology for biomarker discovery
@nl
type
label
Aptamer-based multiplexed proteomic technology for biomarker discovery
@ast
Aptamer-based multiplexed proteomic technology for biomarker discovery
@en
Aptamer-based multiplexed proteomic technology for biomarker discovery
@nl
prefLabel
Aptamer-based multiplexed proteomic technology for biomarker discovery
@ast
Aptamer-based multiplexed proteomic technology for biomarker discovery
@en
Aptamer-based multiplexed proteomic technology for biomarker discovery
@nl
P2093
P2860
P3181
P1433
P1476
Aptamer-based multiplexed proteomic technology for biomarker discovery
@en
P2093
Alana Sterkel
Alex Stewart
Alexey Wolfson
Allison Weiss
Andrew B Dalby
Ashley Bock
Ashley Forbes
Bharat Gawande
Brian Hicke
Bridget Lollo
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0015004
P407
P577
2010-12-07T00:00:00Z